The First Affiliated Hospital with Nanjing Medical University: all 564 studies
Page 1 of 6. Open to participants first (312), then studies with results posted, then the rest; newest registration first within each.
- Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease.Enrolling by invitationNCT07894640Early Phase 1
- Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System LymphomaNot yet recruitingNCT07888621Phase 2
- Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCLRecruitingNCT07884708Phase 2
- Fufang Tongluo Decoction as an Adjunct to Aspirin and Atorvastatin for Ischemic Moyamoya DiseaseEnrolling by invitationNCT07875335Not applicable
- Real-World Study of BCL-2 Inhibitor-Based Regimens in Chronic Lymphocytic LeukemiaRecruitingNCT07874451
- A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With Cetuximab and mFOLFIRI Regimen as First-Line Treatment for Recurrent or Metastatic Colorectal CancerNot yet recruitingNCT07874438Not applicable
- Efficacy and Safety of Intraoperative Radiotherapy Combined With Serplulimab Plus Chemotherapy Versus Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07870798Phase 2
- Ear-Vagus Nerve Stimulation and Body Acupuncture for Gut Motility in Elderly ICU PatientsNot yet recruitingNCT07861503Not applicable
- Electronic PHES vs Paper-based PHES for Hepatic EncephalopathyNot yet recruitingNCT07852416Not applicable
- HER2-positive Breast Cancer Without Intravenous Neoadjuvant TherapyNot yet recruitingNCT07848633Phase 2
- Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II TrialRecruitingNCT07847710Phase 2
- Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic CancerNot yet recruitingNCT07831330Phase 2
- CT-AI Breast Cancer Opportunistic Screening Health Examination StudyNot yet recruitingNCT07809698Not applicable
- Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSFNot yet recruitingNCT07806084
- Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract ReconstructionNot yet recruitingNCT07800819
- ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPRNot yet recruitingNCT07799649
- Heart Rate Variability Changes and Postoperative Delirium After Major Abdominal SurgeryRecruitingNCT07783464
- Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07772557Phase 2
- CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNot yet recruitingNCT07763938Phase 1
- The Efficacy of CAPCT in Patients With PTCLNot yet recruitingNCT07746245Phase 2
- Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II TrialRecruitingNCT07731828Phase 2
- Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)RecruitingNCT07719556Phase 2
- Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal CancerRecruitingNCT07718490Phase 2
- Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ AdenocarcinomaNot yet recruitingNCT07716111Phase 2
- Study on the Thrombolytic Effect of Platelet Membrane Coated Tenecteplase on Human Arterial ThrombusRecruitingNCT07712445
- Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized TrialRecruitingNCT07698366Not applicable
- A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)Not yet recruitingNCT07685236
- Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA FragmentomicsNot yet recruitingNCT07684274
- Dihydroartemisinin for MAFLDRecruitingNCT07679542Phase 1/2
- The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PDNot yet recruitingNCT07679529Not applicable
- Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast CancerNot yet recruitingNCT07677956
- A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL PatientsRecruitingNCT07671378Phase 2
- A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant TherapyNot yet recruitingNCT07669740Phase 2
- An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract MalignanciesRecruitingNCT07668453Phase 2
- Prospective Cohort Study of Local Recurrence After Radical Breast Cancer ResectionNot yet recruitingNCT07668362
- Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel OcclusionRecruitingNCT07668323Phase 3
- Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARCRecruitingNCT07646639Phase 2
- Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLNot yet recruitingNCT07643805Phase 1/2
- Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07628595Early Phase 1
- A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell MalignanciesNot yet recruitingNCT07628582Phase 1
- A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.RecruitingNCT07622836Not applicable
- A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic EncephalopathyNot yet recruitingNCT07612670
- Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 SubtypesRecruitingNCT07608978Phase 2
- Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHPNot yet recruitingNCT07589699Phase 4
- Neoadjuvant SHR-A1811 and SHR-A1701 for Potentially Immunotherapy-Sensitive GC or GEJ AdenocarcinomaNot yet recruitingNCT07581574Phase 1
- RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell LymphomasNot yet recruitingNCT07563543Early Phase 1
- Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 DiabetesRecruitingNCT07558863Phase 4
- Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesRecruitingNCT07558850Not applicable
- Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBCNot yet recruitingNCT07523789
- Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney DiseaseRecruitingNCT07483372Phase 1
- Full-Endoscopic Decompression vs. Endoscopic Lumbar Fusion for Middle-Aged and Older Adults With Spinal StenosisNot yet recruitingNCT07482826Not applicable
- Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical TrialRecruitingNCT07474324Phase 2
- A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT)Not yet recruitingNCT07471165Phase 2
- SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric CancerRecruitingNCT07464756Phase 2
- A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal CancerRecruitingNCT07455019Phase 2
- Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZLRecruitingNCT07448324Phase 2
- Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II StudyRecruitingNCT07446452Phase 2
- Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.Not yet recruitingNCT07444346
- A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic CancerRecruitingNCT07438106Phase 2
- Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular LymphomaRecruitingNCT07418190Phase 2
- Study in Human iPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMDRecruitingNCT07418177Phase 1/2
- PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.RecruitingNCT07410520Phase 2
- Safety of Robotic Surgery for GISTs at Special Anatomic SitesRecruitingNCT07405125Not applicable
- A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary ArteriesRecruitingNCT07400406
- First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With ChemotherapyNot yet recruitingNCT07400315Phase 2
- Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With AnlotinibRecruitingNCT07396454Phase 2
- Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.RecruitingNCT07394387Phase 2
- Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOXNot yet recruitingNCT07391826Phase 2
- Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCLNot yet recruitingNCT07389356Not applicable
- Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled TrialNot yet recruitingNCT07377981Phase 4
- Comparison of Breast Sensory Recovery Between Conventional and Endoscopic Nipple-Sparing Mastectomy Combined With Prepectoral Implant ReconstructionNot yet recruitingNCT07372339Not applicable
- Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and EfficacyEnrolling by invitationNCT07371247Early Phase 1
- To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection in MalesNot yet recruitingNCT07353411Not applicable
- SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell LymphomaNot yet recruitingNCT07347288Phase 2
- Robotic vs Laparoscopic Gastrectomy for cT4a Gastric CancerNot yet recruitingNCT07331454Phase 3
- Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood TumorsNot yet recruitingNCT07330895Early Phase 1
- QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric CancerNot yet recruitingNCT07315035Phase 2
- A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingNCT07294625Early Phase 1
- Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic CancerNot yet recruitingNCT07277452Phase 2
- Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ AdenocarcinomaRecruitingNCT07277439Phase 2
- Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal MetastasisRecruitingNCT07263425Phase 2
- Gestational Lifestyle & Outcomes WellnessRecruitingNCT07263412
- A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric CancerRecruitingNCT07263386Phase 2
- AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CTRecruitingNCT07250347
- The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical StudyRecruitingNCT07240194Phase 2
- 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth TherapyRecruitingNCT07232095Phase 4
- Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpARecruitingNCT07230327
- Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZLRecruitingNCT07208981Phase 2
- Ultrasound-Enhanced Delivery of Compound TXA Solution in MelasmaRecruitingNCT07202156Not applicable
- Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHLRecruitingNCT07195799Phase 2
- Interventional Treatment of Chronic Tinnitus With Acoustic StimulationRecruitingNCT07185061Not applicable
- An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary NodulesRecruitingNCT07185035Early Phase 1
- A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.Not yet recruitingNCT07156643Phase 2
- Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Potentially Resectable MSI-H, dMMR Locally Advanced Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07151209Phase 2
- Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)Not yet recruitingNCT07150195
- Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07148427Phase 2
- Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer (SMARTi-RC01)Not yet recruitingNCT07134101Phase 2
- A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular CarcinomaNot yet recruitingNCT07131501Phase 2
- Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular LymphomaRecruitingNCT07126678Not applicable
- Feasibility and Safety of Laparoscopic Purse-string Suture Clamp and Multi-functional Seal Cap for Totally Laparoscopic Radical Total GastrectomyNot yet recruitingNCT07117812Not applicable
← The First Affiliated Hospital with Nanjing Medical University overview and focus areas